TMEM267: A Potential Drug Target for Various Diseases (G64417)

Target Name: TMEM267

NCBI ID: G64417

TMEM267

TMEM267: A Potential Drug Target for Various Diseases

TMEM267 (TMEM267 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the transmembrane protein family, which means that it spans the cell membrane and is involved in various cellular processes.

TMEM267 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function in these diseases has been studied extensively, and its potential as a drug target has led to the development of several investigational compounds.

One of the key features of TMEM267 is its ability to interact with various signaling pathways, including TGF-β, NF-kappa-B, and PI3K. These signaling pathways are involved in various cellular processes that are important for the development and progression of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TMEM267 has been shown to be involved in the regulation of cell proliferation, migration, and survival. It has been shown to play a role in the development of various types of cancer, including breast, ovarian, and colorectal cancer. It has also been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its involvement in disease, TMEM267 has also been shown to be a potential drug target. Several investigational compounds have been developed to target TMEM267 and have been shown to have potential therapeutic effects. These compounds have been shown to inhibit TMEM267's activity in various cellular processes, including cell proliferation, migration, and survival.

TMEM267 has also been shown to be involved in the regulation of pain perception and neuroinflammation. Its involvement in these processes has led to the development of several compounds with potential therapeutic effects in the treatment of pain and neuroinflammation.

Overall, TMEM267 is a protein that has significant involvement in various cellular processes that are important for the development and progression of diseases. Its potential as a drug target or biomarker has led to the development of several investigational compounds that have the potential to treat a wide range of diseases. Further research is needed to fully understand TMEM267's role in these diseases and to develop safe and effective therapies.

Protein Name: Transmembrane Protein 267

The "TMEM267 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM267 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets